SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambalal Sarabhai Ent reports Profit after tax of Rs -20.23 Mln, in the June 2023 quarter

10 Aug 2023 Evaluate
The sales for the June 2023 quarter moved up 42.95% to Rs. 17.04 millions as compared to Rs. 11.92 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -20.23 millions as compared to Net Profit of Rs. 8.55 millions of corresponding quarter ended June 2022Operating profit Margin for the quarter ended June 2023 slipped to -19.69% as compared to 9.78% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 17.04 11.92 42.95 17.04 11.92 42.95 37.07 1.27 2818.90
Other Income 11.81 24.09 -50.98 11.81 24.09 -50.98 105.34 395.35 -73.36
PBIDT -19.69 9.78 -301.33 -19.69 9.78 -301.33 53.76 339.68 -84.17
Interest 0.25 0.33 -24.24 0.25 0.33 -24.24 1.07 2.47 -56.68
PBDT -19.94 9.02 -321.06 -19.94 9.02 -321.06 44.81 36.44 22.97
Depreciation 0.29 0.42 -30.95 0.29 0.42 -30.95 1.45 1.92 -24.48
PBT -20.23 8.60 -335.23 -20.23 8.60 -335.23 43.36 34.52 25.61
TAX 0.00 0.05 0.00 0.00 0.05 0.00 2.26 4.96 -54.44
Deferred Tax 0.00 0.05 0.00 0.00 0.05 0.00 2.26 7.46 -69.71
PAT -20.23 8.55 -336.61 -20.23 8.55 -336.61 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) -115.55 82.05 -240.84 -115.55 82.05 -240.84 145.02 26746.46 -99.46

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×